448 related articles for article (PubMed ID: 30103095)
1. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
2. Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.
Hsieh FS; Chen YL; Hung MH; Chu PY; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Chang MJ; Chao TI; Shiau CW; Chen KF
Mol Oncol; 2017 Aug; 11(8):1035-1049. PubMed ID: 28453226
[TBL] [Abstract][Full Text] [Related]
3. P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy.
Fernández-Aroca DM; Roche O; Sabater S; Pascual-Serra R; Ortega-Muelas M; Sánchez Pérez I; Belandia B; Ruiz-Hidalgo MJ; Sánchez-Prieto R
Cancer Lett; 2019 Jun; 451():23-33. PubMed ID: 30872077
[TBL] [Abstract][Full Text] [Related]
4. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo.
Tao Z; Le Blanc JM; Wang C; Zhan T; Zhuang H; Wang P; Yuan Z; Lu B
Clin Cancer Res; 2016 Jan; 22(1):122-33. PubMed ID: 26728409
[TBL] [Abstract][Full Text] [Related]
5. DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy.
Chua ML; Horn S; Somaiah N; Davies S; Gothard L; A'Hern R; Yarnold J; Rothkamm K
Radiat Environ Biophys; 2014 May; 53(2):355-64. PubMed ID: 24622963
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
8. DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer.
Wu J; Galvan KJ; Bogard RD; Peterson CE; Shergill A; Crowe DL
Anticancer Res; 2021 Nov; 41(11):5393-5403. PubMed ID: 34732408
[TBL] [Abstract][Full Text] [Related]
9. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.
Bollard J; Miguela V; Ruiz de Galarreta M; Venkatesh A; Bian CB; Roberto MP; Tovar V; Sia D; Molina-Sánchez P; Nguyen CB; Nakagawa S; Llovet JM; Hoshida Y; Lujambio A
Gut; 2017 Jul; 66(7):1286-1296. PubMed ID: 27849562
[TBL] [Abstract][Full Text] [Related]
10. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
[TBL] [Abstract][Full Text] [Related]
11. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.
Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G
Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582
[TBL] [Abstract][Full Text] [Related]
13. Zerumbone Regulates DNA Repair Responding to Ionizing Radiation and Enhances Radiosensitivity of Human Prostatic Cancer Cells.
Chiang PK; Tsai WK; Chen M; Lin WR; Chow YC; Lee CC; Hsu JM; Chen YJ
Integr Cancer Ther; 2018 Jun; 17(2):292-298. PubMed ID: 28602099
[TBL] [Abstract][Full Text] [Related]
14. Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.
Wild AT; Gandhi N; Chettiar ST; Aziz K; Gajula RP; Williams RD; Kumar R; Taparra K; Zeng J; Cades JA; Velarde E; Menon S; Geschwind JF; Cosgrove D; Pawlik TM; Maitra A; Wong J; Hales RK; Torbenson MS; Herman JM; Tran PT
PLoS One; 2013; 8(6):e65726. PubMed ID: 23762417
[TBL] [Abstract][Full Text] [Related]
15. Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
Raymond AA; Benhamouche S; Neaud V; Di Martino J; Javary J; Rosenbaum J
PLoS One; 2015; 10(4):e0123333. PubMed ID: 25875766
[TBL] [Abstract][Full Text] [Related]
16. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
Mirzayans R; Severin D; Murray D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma.
Gil del Alcazar CR; Hardebeck MC; Mukherjee B; Tomimatsu N; Gao X; Yan J; Xie XJ; Bachoo R; Li L; Habib AA; Burma S
Clin Cancer Res; 2014 Mar; 20(5):1235-48. PubMed ID: 24366691
[TBL] [Abstract][Full Text] [Related]
18. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells.
Moolmuang B; Ruchirawat M
J Pharm Pharmacol; 2021 Mar; 73(1):40-51. PubMed ID: 33791808
[TBL] [Abstract][Full Text] [Related]
19. RNF8 promotes high linear energy transfer carbon-ion-induced DNA double-stranded break repair in serum-starved human cells.
Nakajima NI; Yamauchi M; Kakoti S; Cuihua L; Kato R; Permata TBM; Iijima M; Yajima H; Yasuhara T; Yamada S; Hasegawa S; Shibata A
DNA Repair (Amst); 2020; 91-92():102872. PubMed ID: 32502756
[TBL] [Abstract][Full Text] [Related]
20. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
